Hospital Medicine News

The FDA has approved Zimhi, a high-dose naloxone product that is administered through a prefilled syringe to counteract potentially fatal opioid overdoses, the agency and the drug’s manufacturer announced.

The FDA has granted 510(k) clearance to Siemens Medical Solutions Inc. for the Siemens Naeotom Alpha, a new advancement in diagnostic CT imaging, according to a company press release.

Administering a beta-lactam antibiotic before vancomycin significantly reduced mortality rates among patients being treated for bloodstream infections, according to a study published in Clinical Infectious Diseases.

More than 140,000 children in the U.S. have lost a primary or secondary caregiver due to the COVID-19 pandemic, according to findings published in Pediatrics.

Medicare beneficiaries have limited access to recommended treatments for Clostridioides difficile infection, researchers reported in Clinical Infectious Diseases.

A virtual reality intervention called “Bear Blast” significantly decreased pain and anxiety among children and teenagers while they underwent peripheral IV catheter placement, trial data showed.

The antibody cocktail of casirivimab and imdevimab significantly reduced viral loads in hospitalized patients with COVID-19 who were receiving low-flow or no supplemental oxygen, data presented at IDWeek showed.

The rate of children who presented to nine pediatric trauma centers for nonaccidental trauma more than doubled while COVID-19 stay-at-home orders were in place last year, according to a study.

The implementation of a mandatory prescription drug monitoring program led to an immediate decrease in opioid prescribing in three surgical specialties, according to findings published in JAMA Health Forum.

Johnson & Johnson said Tuesday that it has asked the FDA to authorize a booster dose of its one-shot COVID-19 vaccine for people aged 18 years or older.